Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 44.08M | 46.58M | 49.04M | 50.22M | 51.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.08M | 46.58M | 49.04M | 50.22M | 51.47M |
| Cost of Revenue | 18.16M | 19.10M | 20.08M | 20.19M | 20.20M |
| Gross Profit | 25.92M | 27.48M | 28.96M | 30.04M | 31.27M |
| SG&A Expenses | 7.01M | 8.08M | 9.06M | 10.04M | 11.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.01M | 27.99M | 29.82M | 30.79M | 31.89M |
| Operating Income | 18.07M | 18.59M | 19.22M | 19.44M | 19.57M |
| Income Before Tax | 18.21M | 18.81M | 19.77M | 20.09M | 20.66M |
| Income Tax Expenses | 2.95M | 3.18M | 3.39M | 3.45M | 3.76M |
| Earnings from Continuing Operations | 15.26 | 15.63 | 16.38 | 16.64 | 16.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.26M | 15.63M | 16.38M | 16.64M | 16.90M |
| EBIT | 18.07M | 18.59M | 19.22M | 19.44M | 19.57M |
| EBITDA | 21.17M | 22.74M | 24.46M | 25.75M | 26.60M |
| EPS Basic | 4.28 | 4.34 | 4.52 | 4.58 | 4.66 |
| Normalized Basic EPS | 3.79 | 3.84 | 3.92 | 3.92 | 3.84 |
| EPS Diluted | 4.27 | 4.33 | 4.50 | 4.57 | 4.64 |
| Normalized Diluted EPS | 3.79 | 3.84 | 3.92 | 3.91 | 3.84 |
| Average Basic Shares Outstanding | 14.26M | 14.41M | 14.51M | 14.52M | 14.52M |
| Average Diluted Shares Outstanding | 14.26M | 14.42M | 14.53M | 14.55M | 14.55M |
| Dividend Per Share | 1.20 | 1.20 | 1.19 | 1.19 | 1.18 |
| Payout Ratio | 28.14% | 27.59% | 26.26% | 25.74% | 25.21% |
